Home
About Us
- Team
- Careers
Product & Technology
Investors
News & Events
- Press
Contact

FDA Clearance

MammoScreen received 510(k) clearance

July 9, 2020

Therapixel receives FDA 510(k) clearance for MammoScreen™

AI-powered reading aid for screening mammography improves…

by Ekaterina Sinichkina

Text

Therapixel is one of the leading French software companies specialising in artificial intelligence applied to medical imaging.

LATEST BLOG NEWS

Therapixel will be showcasing MammoScreen™ at the virtual ECR 2021 February 25, 2021
Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™ January 12, 2021
Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health October 16, 2020

RECOMMENDED POSTS

Therapixel secures a €5 million Series A financing and strengthens its governance
Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™
Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health
Scientific Publications
Therapixel participates in the Journées Francophones de Radiologie 2020

© 2020 Therapixel | Web design by Domaine-Pack.fr

Privacy Preference Center

Privacy Preferences